pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05552664: The Genetic Information and Family Testing (GIFT) Study

Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07311564: A Study of LAD603 in Adults With Alopecia Areata

Sponsor: Almirall, S.A.. Phase: PHASE2. Conditions: Alopecia Areata

full page →ctgov ↗
›RECRUITINGphase readoutNCT03664609: Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor: Boston Scientific Corporation. Phase: . Conditions: Parkinson Disease, Essential Tremor, Dystonia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07264699: Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair

Sponsor: University of Warmia and Mazury in Olsztyn. Phase: NA. Conditions: Inguinal Hernia Repair, Postoperative Pain, TAP Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT04341532: Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations

Sponsor: National Jewish Health. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07262632: Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment

Sponsor: Dr. Mark Mulder. Phase: . Conditions: Cancer-related Pain, Pain Assessment, Artificial Intelligence (AI), Oncology, Oncology Pain, Database, Facial Expression, Voice, Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06113198: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Sponsor: GlaxoSmithKline. Phase: PHASE4. Conditions: Meningitis, Meningococcal

full page →ctgov ↗
›AVAILABLEphase readoutNCT04566393: Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Sponsor: xCures. Phase: . Conditions: Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer, Melanoma, Non Small Cell Lung Cancer, Thyroid Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Esophageal Cancer, Cholangiocarcinoma, Ovarian Cancer, Hepatocellular Carcinoma, Glioblastoma, MAPK Gene Mutation, KRAS Activating Mutation, BRAF Gene Mutation, NRAS Gene Mutation, HRAS Gene Mutation, MEK Mutation, ERK Mutation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07334093: A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Cancer Therapy-induced Thrombocytopenia (CTIT)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07301021: Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Phase: . Conditions: Velopharyngeal Insufficiency, Swallowing, Nasality, Speech

full page →ctgov ↗
›RECRUITINGphase readoutNCT05837221: Microbiome in Head and Neck Squamous Cell Carcinoma

Sponsor: University of Colorado, Denver. Phase: . Conditions: Head and Neck Cancer, Lip Cancer, Oral Cancer, Pharynx Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380321: Diaphragm Ultrasound İn Children With OSAS

Sponsor: Istanbul University. Phase: . Conditions: Obstructive Sleep Apnea of Child

full page →ctgov ↗
›COMPLETEDphase readoutNCT07057921: The Learning Curve of Video Laryngeal Mask Airway (Video-LMA) Use in Airway Management by Anesthesiology Residents

Sponsor: Samsun University. Phase: . Conditions: Laryngeal Mask Airways, Airway Devices

full page →ctgov ↗
›RECRUITINGphase readoutNCT07374614: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib

Sponsor: Peking University Shenzhen Hospital. Phase: . Conditions: Non-Small Cell Lung Cancer, ALK, Iruplinalkib, Lorlatinib, Real-world Study, Observational Study

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07442214: View of Cerebral Perfusion in Liver Transplantation

Sponsor: Inonu University. Phase: . Conditions: End-stage Liver Disease (ESLD), Liver Transplantation, Cerebral Perfusion, Intraoperative Monitoring

full page →ctgov ↗
›COMPLETEDphase readoutNCT02957916: Vanderbilt Childhood Obesity Registry

Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Childhood Onset Obesity, Pediatric Obesity, Childhood Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394816: Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Postoperative Pulmonary Complications (PPCs), Abdominal Surgeries, Postoperative Pain Management

full page →ctgov ↗
›RECRUITINGphase readoutNCT05482906: Common and Specific Information From Neuroimaging and Smartphone

Sponsor: Nantes University Hospital. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06910306: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Sponsor: Alpha Tau Medical LTD.. Phase: NA. Conditions: Recurrent Glioblastoma, Recurrent Gliomas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07543484: Kinematics and Muscle Activity During the Tennis Serve and Musculoskeletal Characteristics in Tennis Players With Subacromial Pain Syndrome or History of Shoulder Pain

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Shoulder Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07486505: Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, Mindfulness-based Intervention to Manage Pain and Anxiety Before and After Fracture Surgery

Sponsor: McMaster University. Phase: NA. Conditions: Orthopaedic Fractures, Orthopaedic Trauma Fractures and Non-unions, Orthopaedic Trauma, Orthopaedic Surgery, Orthopaedic Related Pain (Musculoskeletal Pain), Anxiety Acute, Anxiety After Surgery, Opioid Use, Opioid Use After Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07195994: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Sponsor: QuickSilver Scientific. Phase: NA. Conditions: Prediabetes / Type 2 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07504094: Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Chronic Back Pain, Chronic Pain, Back Pain, Low Back Pain, Chronic, Musculoskeletal Pain, Kinesiophobia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02616666: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

Sponsor: University of Liverpool. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07206056: An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Progressive Metastatic Castrate Resistant Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00092222: Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07556822: Phase I Study of HRS-3005 in B-cell Malignancies

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: B-cell Malignancy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06368622: Evolve China PMCF Study

Sponsor: Stryker Neurovascular. Phase: . Conditions: Intracranial Aneurysm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06835751: Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: HIV, Mental Health, Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05397951: The Validation Study of Bioelectronics

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Healthy, Health Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT07142551: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07089329: Efficacy of Striatin in Malnourished Children

Sponsor: Universitas Sriwijaya. Phase: PHASE3. Conditions: Severe Acute Malnutrition

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504029: Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides

Sponsor: Chung Shan Medical University. Phase: NA. Conditions: People With Prediabetic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07378553: Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies

Sponsor: Nantes University Hospital. Phase: . Conditions: Duchene Muscular Dystrophy, Becker Muscular Dystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07410637: Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Sponsor: University of Ulm. Phase: NA. Conditions: Graves Disease, Thyroid Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03093337: Psychomotor Therapy for Very Premature Infants

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06476145: Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Sponsor: AdventHealth. Phase: . Conditions: Adenoma Colon Polyp

full page →ctgov ↗
›RECRUITINGphase readoutNCT06665295: THRIVE-CAR-T Digital App

Sponsor: Patrick C. Johnson, MD. Phase: NA. Conditions: CAR T-Cell Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07124377: Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Sponsor: Hospital 9 de Julio de Las Breñas. Phase: . Conditions: Hereditary Amyloidosis, Transthyretin-Related

full page →ctgov ↗
›COMPLETEDphase readoutNCT04985877: Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota in Sarcopenia Elderly

Sponsor: Taipei Medical University. Phase: NA. Conditions: Sarcopenia, Inflammation, Aging

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07477977: Dose for Reversal of Heparin After Cardiopulmonary Bypass

Sponsor: Sohag University. Phase: NA. Conditions: Open Heart Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06077877: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT07313475: Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Lupus Anticoagulant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06623357: Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. Phase: NA. Conditions: Brachial Plexus Birth Palsy, Erbs Palsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06267001: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06608901: A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Sepsis-Induced Hypotension

full page →ctgov ↗
›COMPLETEDphase readoutNCT05423912: Keeping on Course: A Communication-Focused Psychoeducational Program

Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03500081: Solid Tumor Imaging MR-Linac (STIM Study)

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07388719: Comparison of Standard Versus Dynamic Compliance-Guided Individualized PEEP in Obese Patients Undergoing Spinal Surgery

Sponsor: Konya City Hospital. Phase: NA. Conditions: Obesity, Postoperative Pulmonary Complications, Mechanical Ventilation

full page →ctgov ↗
›COMPLETEDphase readoutNCT04238819: A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Relapsed Solid Tumor, Refractory Solid Tumor

full page →ctgov ↗
← prev
page 62 of 156
next →